{"description":"Guidelines: Expression profiling - best practices for data generation and interpretation in clinical trialsNat Rev Genet 2004 Mar;5(3):229-237Affymetrics \u306e\u65b9\u3005\u306b\u3088\u308b\uff0cTumor Analysis Best Practices Working Group \u306e\u6d3b\u52d5\u7d39\u4ecb\u3068\u3044\u3046\u4f4d\u7f6e\u4ed8\u3051\u304b\u306a? MGED \u306e\u72d9\u3044\u3068\u306f\u5fae\u5999\u306b\u7570\u306a\u308a\uff0c \u3044\u304b\u306b\u591a\u6a5f\u95a2\u306b\u308f\u305f\u3063\u3066\u6bd4\u8f03\u53ef\u80fd\u306a\u30c7\u30fc\u30bf\u3092\u4f5c\u6210\u3059\u308b\u304b (inter-laboratories comparability \u50d5\u2026","provider_url":"https://hatena.blog","blog_url":"https://ktaz.hatenadiary.org/","url":"https://ktaz.hatenadiary.org/entry/20040305/1078442694","width":"100%","provider_name":"Hatena Blog","published":"2004-03-05 08:24:54","author_name":"ktaz","image_url":null,"html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Fktaz.hatenadiary.org%2Fentry%2F20040305%2F1078442694\" title=\" - ktaz\u306e\u8ad6\u6587\u30e1\u30e2\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","type":"rich","blog_title":"ktaz\u306e\u8ad6\u6587\u30e1\u30e2","height":"190","categories":["\u8ad6\u6587"],"title":"","author_url":"https://blog.hatena.ne.jp/ktaz/","version":"1.0"}